---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-008696"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2023-12-07T23:59:59+00:00"
generated_at: "2026-06-07T16:05:21.865745+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma annual meeting: directors elected, reverse split up to 1:40 approved

## Summary
- All five director nominees elected with >16M votes each; broker non-votes 5.04M.
- Ratification of BF Borgers as auditor approved: 20.1M for, 2.45M against.
- 2023 Equity Incentive Plan approved: 15.9M for, 1.84M against.
- Reverse stock split authorized at ratio between 1:2 and 1:40, board discretion on timing.
- Advisory vote on executive compensation approved; frequency set at every 3 years.

## SEC filing metadata
- accession: 0001683168-23-008696
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2023-12-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316823008696/0001683168-23-008696-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316823008696/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-008696
- JSON: https://secwatch.observer/filing/0001683168-23-008696.json
- Plain text: https://secwatch.observer/filing/0001683168-23-008696.txt

## Key facts
- Shareholder Votes
  Sunshine Biopharma Inc. shareholders approved Election of directors at the 2023-12-07 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-12-07
  source text: At the meeting, (i) Dr. Steve N. Slilaty, Dr. Abderrazzak Merzouki, Dr. Rabi Kiderchah, Mr. David Natan, and Dr. Andrew Keller were each elected as directors of the Company to serve until the next annual meeting of stockholders or until their successors have been elected and qualified
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402328/000168316823008696/0001683168-23-008696-index.htm
- Shareholder Votes
  Sunshine Biopharma Inc. shareholders approved Ratification of the board of directors’ appointment of BF Borgers, CPA P.C. as the Company’s independent registered public accounting firm for 2023 at the 2023-12-07 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-12-07
  source text: Ratification of the board of directors’ appointment of BF Borgers, CPA P.C. as the Company’s independent registered public accounting firm for 2023. FOR AGAINST ABSTAIN 20,099,526 2,452,753 418,180
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402328/000168316823008696/0001683168-23-008696-index.htm
- Shareholder Votes
  Sunshine Biopharma Inc. shareholders approved Advisory vote on frequency of future advisory votes on executive compensation at the 2023-12-07 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-12-07
  source text: Advisory vote on frequency of future advisory votes on executive compensation. 1 YEAR 2 YEARS 3 YEARS ABSTAIN BROKER NON-VOTE 1,777,275 165,011 15,063,931 923,289 5,040,953
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402328/000168316823008696/0001683168-23-008696-index.htm
- Shareholder Votes
  Sunshine Biopharma Inc. shareholders approved Approval of the Company’s 2023 Equity Incentive Plan at the 2023-12-07 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-12-07
  source text: Approval of the Company’s 2023 Equity Incentive Plan. FOR AGAINST ABSTAIN BROKER NON-VOTE 15,915,610 1,842,630 171,266 5,040,953
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402328/000168316823008696/0001683168-23-008696-index.htm
- Shareholder Votes
  Sunshine Biopharma Inc. shareholders approved Advisory vote on executive compensation at the 2023-12-07 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-12-07
  source text: Advisory vote on executive compensation. FOR AGAINST ABSTAIN BROKER NON-VOTE 16,196,664 1,516,235 216,607 5,040,953
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402328/000168316823008696/0001683168-23-008696-index.htm
- Shareholder Votes
  Sunshine Biopharma Inc. shareholders approved Approval of a reverse stock split of the Company’s common stock by a ratio of not less than 1-for-2 and not more than 1-for-40 at the 2023-12-07 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-12-07
  source text: Approval of reverse stock split. FOR AGAINST ABSTAIN 20,005,507 2,657,164 307,788
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402328/000168316823008696/0001683168-23-008696-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.